News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
685,669 Results
Type
Article (39052)
Company Profile (279)
Press Release (646338)
Section
Business (203882)
Career Advice (1991)
Deals (35363)
Drug Delivery (85)
Drug Development (80800)
Employer Resources (168)
FDA (16088)
Job Trends (14805)
News (344563)
Policy (32437)
Tag
Academia (2530)
Alliances (49087)
Alzheimer's disease (1229)
Approvals (16020)
Artificial intelligence (130)
Bankruptcy (352)
Best Places to Work (11538)
Biotechnology (200)
Breast cancer (120)
Cancer (1087)
Cardiovascular disease (97)
Career advice (1660)
Cell therapy (234)
Clinical research (64252)
Collaboration (388)
Compensation (200)
COVID-19 (2530)
C-suite (94)
Data (1126)
Diabetes (152)
Diagnostics (6139)
Earnings (84836)
Employer resources (146)
Events (109495)
Executive appointments (310)
FDA (16627)
Funding (353)
Gene therapy (178)
GLP-1 (577)
Government (4325)
Healthcare (18669)
Infectious disease (2615)
Inflammatory bowel disease (106)
Interviews (308)
IPO (16303)
Job creations (3624)
Job search strategy (1417)
Layoffs (412)
Legal (7853)
Lung cancer (170)
Manufacturing (176)
Medical device (13174)
Medtech (13179)
Mergers & acquisitions (19141)
Metabolic disorders (402)
Neuroscience (1504)
NextGen Class of 2024 (6499)
Non-profit (4464)
Northern California (1481)
Obesity (232)
Opinion (179)
Patents (102)
People (56275)
Phase I (19955)
Phase II (28303)
Phase III (21099)
Pipeline (458)
Postmarket research (2554)
Preclinical (8494)
Radiopharmaceuticals (236)
Rare diseases (219)
Real estate (5890)
Regulatory (21525)
Research institute (2309)
Resumes & cover letters (349)
Southern California (1302)
Startups (3562)
United States (13502)
Vaccines (549)
Weight loss (168)
Date
Today (1)
Last 7 days (667)
Last 30 days (3561)
Last 365 days (35660)
2024 (32755)
2023 (40081)
2022 (51178)
2021 (55715)
2020 (54089)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37553)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (192)
Asia (37123)
Australia (6059)
California (3331)
Canada (1295)
China (252)
Colorado (147)
Connecticut (153)
Europe (79507)
Florida (461)
Georgia (116)
Illinois (341)
Indiana (196)
Kansas (96)
Maryland (575)
Massachusetts (2611)
Michigan (158)
Minnesota (273)
New Jersey (957)
New York (964)
North Carolina (702)
Northern California (1481)
Ohio (139)
Pennsylvania (847)
South America (1091)
Southern California (1302)
Texas (465)
Utah (90)
Washington State (362)
685,669 Results for "stereotaxis inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Stereotaxis Reports 2024 Third Quarter Financial Results
November 12, 2024
·
9 min read
Deals
Stereotaxis Announces Definitive Agreement to Acquire Access Point Technologies
Stereotaxis announced that it has entered into a definitive share purchase agreement under which Stereotaxis will acquire Access Point Technologies EP, a privately-held Minnesota-based developer of innovative electrophysiology catheters.
May 13, 2024
·
6 min read
Press Releases
Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation
October 22, 2024
·
3 min read
Business
Stereotaxis Reports 2024 First Quarter Financial Results
Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the first quarter ended March 31, 2024.
May 13, 2024
·
7 min read
Press Releases
Stereotaxis to Present at Upcoming Investor Conferences
September 9, 2024
·
2 min read
Business
Stereotaxis to Report Third Quarter 2024 Financial Results on November 11, 2024
October 23, 2024
·
1 min read
BioMidwest
Stereotaxis Receives CE Mark Recertification Under EU’s MDR Regulatory Framework
Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, announced that it has received CE Mark recertification under the European Union’s new Medical Device Regulation regulatory framework.
May 24, 2024
·
3 min read
Business
Stereotaxis to Report First Quarter 2024 Financial Results on May 13, 2024
Stereotaxis today announced that it will release financial results for its 2024 first quarter on Monday, May 13, 2024 at the close of the U.S. financial markets.
April 22, 2024
·
1 min read
Business
Stereotaxis Reports 2024 Second Quarter Financial Results
August 12, 2024
·
7 min read
Business
Stereotaxis Reports 2023 Full Year Financial Results
Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the fourth quarter and full year ended December 31, 2023.
March 4, 2024
·
9 min read
1 of 68,567
Next
